Atossa Therapeutics
ATOS
#9930
Rank
NZ$60.63 M
Marketcap
NZ$7.04
Share price
-4.75%
Change (1 day)
406.22%
Change (1 year)

Market capitalization of Atossa Therapeutics (ATOS)

Market cap: NZ$60.63 Million

As of February 2026 Atossa Therapeutics has a market cap of NZ$60.63 Million. This makes Atossa Therapeutics the world's 9930th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atossa Therapeutics from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$60.63 M-58.74%
2025NZ$0.14 B-32.85%
2024NZ$0.21 B25.51%
2023NZ$0.17 B65.42%
2022NZ$0.10 B-64.46%
2021NZ$0.29 B373.79%
2020NZ$62.6 M194.11%
2019NZ$21.28 M139.42%
2018NZ$8.89 M-24.56%
2017NZ$11.78 M52.84%
2016NZ$7.71 M-49.5%
2015NZ$15.26 M-65.94%
2014NZ$44.83 M-14.51%
2013NZ$52.43 M-14.38%
2012NZ$61.24 M

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$977.42 B 1,611,789.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$37.66 B 62,007.61%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$39.28 B 64,692.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$4.72 B 7,689.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ$2.14 B 3,429.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ$61.19 M 0.92%๐Ÿ‡บ๐Ÿ‡ธ USA